Michael C G Stevens

Summary

Affiliation: University of Bristol
Country: UK

Publications

  1. ncbi request reprint Treatment for childhood rhabdomyosarcoma: the cost of cure
    Michael C G Stevens
    Department of Oncology, Bristol Royal Hospital for Children, Bristol, UK
    Lancet Oncol 6:77-84. 2005
  2. ncbi request reprint Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89
    Michael C G Stevens
    University of Bristol, Bristol, United Kingdom
    J Clin Oncol 23:2618-28. 2005
  3. ncbi request reprint Cure at what cost?
    Michael C G Stevens
    Academic Unit of Paediatric Oncology, University of Bristol, United Kingdom
    Eur J Cancer 41:2701-3. 2005
  4. doi request reprint Family, demographic and illness-related determinants of HRQL in children with brain tumours in the first year after diagnosis
    Anthony Penn
    Department of Paediatric Neurology, Frenchay Hospital, Bristol, UK
    Pediatr Blood Cancer 53:1092-9. 2009
  5. ncbi request reprint Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology
    Richard J Stewart
    Queen s Medical Centre, Nottingham, United Kingdom
    J Clin Oncol 21:793-8. 2003
  6. doi request reprint Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups
    Odile Oberlin
    Department of Paediatric Oncology, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France
    J Clin Oncol 26:2384-9. 2008
  7. ncbi request reprint The 'Lost Tribe' and the need for a promised land: the challenge of cancer in teenagers and young adults
    Michael C G Stevens
    Eur J Cancer 42:280-1. 2006
  8. ncbi request reprint Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology
    Marie Pierre Castex
    Hematology Oncology and Orthopedic Surgery Units, Children s Hospital, Toulouse, France
    J Clin Oncol 25:1176-82. 2007
  9. doi request reprint Extent of smoking and age at initiation of smoking among adult survivors of childhood cancer in Britain
    Clare Frobisher
    Department of Public Health and Epidemiology, Centre for Childhood Cancer Survivor Studies, University of Birmingham, Birmingham B15 2TT, UK
    J Natl Cancer Inst 100:1068-81. 2008

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Treatment for childhood rhabdomyosarcoma: the cost of cure
    Michael C G Stevens
    Department of Oncology, Bristol Royal Hospital for Children, Bristol, UK
    Lancet Oncol 6:77-84. 2005
    ..An important issue is the overall cost of cure in relation to the treatment received and the need for better selection of patients most likely to benefit from this approach to therapy...
  2. ncbi request reprint Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89
    Michael C G Stevens
    University of Bristol, Bristol, United Kingdom
    J Clin Oncol 23:2618-28. 2005
    ..To improve outcome for children with nonmetastatic rhabdomyosarcoma and to reduce systematic use of local therapy...
  3. ncbi request reprint Cure at what cost?
    Michael C G Stevens
    Academic Unit of Paediatric Oncology, University of Bristol, United Kingdom
    Eur J Cancer 41:2701-3. 2005
  4. doi request reprint Family, demographic and illness-related determinants of HRQL in children with brain tumours in the first year after diagnosis
    Anthony Penn
    Department of Paediatric Neurology, Frenchay Hospital, Bristol, UK
    Pediatr Blood Cancer 53:1092-9. 2009
    ....
  5. ncbi request reprint Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology
    Richard J Stewart
    Queen s Medical Centre, Nottingham, United Kingdom
    J Clin Oncol 21:793-8. 2003
    ..To report the results of the Malignant Mesenchymal Tumors studies (MMT 84 and 89) of the International Society of Pediatric Oncology (SIOP) in males with nonmetastatic paratesticular rhabdomyosarcoma...
  6. doi request reprint Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups
    Odile Oberlin
    Department of Paediatric Oncology, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif Cedex, France
    J Clin Oncol 26:2384-9. 2008
    ..To identify risk factors associated with outcome in children with metastatic rhabdomyosarcoma in a large cohort of patients..
  7. ncbi request reprint The 'Lost Tribe' and the need for a promised land: the challenge of cancer in teenagers and young adults
    Michael C G Stevens
    Eur J Cancer 42:280-1. 2006
  8. ncbi request reprint Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology
    Marie Pierre Castex
    Hematology Oncology and Orthopedic Surgery Units, Children s Hospital, Toulouse, France
    J Clin Oncol 25:1176-82. 2007
    ..To evaluate the outcome of children with an extraosseous Ewing tumor (EOE) according to treatment...
  9. doi request reprint Extent of smoking and age at initiation of smoking among adult survivors of childhood cancer in Britain
    Clare Frobisher
    Department of Public Health and Epidemiology, Centre for Childhood Cancer Survivor Studies, University of Birmingham, Birmingham B15 2TT, UK
    J Natl Cancer Inst 100:1068-81. 2008
    ....